Join us in Prague, Czech Republic for RNA Horizons 2027
Join us for RNA Horizons 2027, taking place September 21-23, 2027, in Prague, Czech Republic. This premier event unites leading researchers, clinicians and biotech innovators to explore the latest advances in RNA therapeutics – from established modalities to emerging areas such as ASOs and RNA structure-based therapies.
Discussions will follow the trends shaping the field: Pipeline diversification, enhanced RNA modalities, AI integration and improved delivery technologies. Just as importantly, the conference will address how discoveries become viable therapies, exploring commercialization and market access.
Connect with leading scientists, clinicians and biotech innovators to explore the latest frontiers in RNA biology and therapeutic innovation.
Key Research Areas
RNA Horizons 2027 will delve into the following key research areas:
- RNA Processing & Mis-Splicing in Human Disease
- Epitranscriptomic Regulation in Cancer, Immunity & Aging
- RNA-Based Immune Modulation
- mRNA Vaccines & Personalized RNA Immunotherapy
- RNA Therapeutics for Genetic & Rare Disorders
- RNA Biomarkers & Precision Medicine
- RNA-Mediated Tumor Microenvironment Modulation
- RNA Delivery Technologies
- Non-coding RNAs as Drug Targets
- AI in RNA Medicine
RNA Horizons 2027 Organizing Committee
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Principal Investigator, Perelman School of Medicine
University of Pennsylvania, Philadelphia, USA
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, Paris, France
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, New York, NY, USA
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Rome, Italy
Director of the Sharett Institute of Oncology
Hadassah Medical Center, Jerusalem, Israel
Our events
ORGANIZERS
